| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Duffy Sean P. | Chief Executive Officer, Director | C/O OMADA HEALTH, INC., 611 GATEWAY BLVD, SUITE 120, SOUTH SAN FRANCISCO | /s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy | 14 Jan 2026 | 0002069522 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OMDA | Common Stock | Options Exercise | $587,721 | +230,479 | +182% | $2.55 | 357,123 | 12 Jan 2026 | Direct | |
| transaction | OMDA | Common Stock | Sale | $2,148,425 | -139,989 | -39% | $15.35 | 217,134 | 12 Jan 2026 | Direct | F1, F2 |
| transaction | OMDA | Common Stock | Sale | $1,446,727 | -90,490 | -42% | $15.99 | 126,644 | 12 Jan 2026 | Direct | F1, F3 |
| transaction | OMDA | Common Stock | Options Exercise | $104,030 | +40,796 | +32% | $2.55 | 167,440 | 13 Jan 2026 | Direct | |
| transaction | OMDA | Common Stock | Sale | $650,774 | -40,796 | -24% | $15.95 | 126,644 | 13 Jan 2026 | Direct | F1, F4 |
| holding | OMDA | Common Stock | 861,109 | 12 Jan 2026 | See footnote | F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OMDA | Stock Option (Right to Buy) | Options Exercise | $0 | -230,479 | -85% | $0.000000 | 40,796 | 12 Jan 2026 | Common Stock | 230,479 | $2.55 | Direct | F6 |
| transaction | OMDA | Stock Option (Right to Buy) | Options Exercise | $0 | -40,796 | -100% | $0.000000 | 0 | 13 Jan 2026 | Common Stock | 40,796 | $2.55 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | Represents shares underlying non-qualified stock options set to expire imminently on January 27, 2026. |
| F2 | This transaction was executed in multiple trades at prices ranging from $14.85 to $15.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $15.85 to $16.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $15.61 to $16.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein. |
| F6 | The option is fully vested and exercisable. |